The 60 rating InvestorsObserver gives to Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock puts it near the top of the Medical Devices industry. In addition to scoring higher than 79 percent of stocks in the Medical Devices industry, BIO’s 60 overall rating means the stock scores better than 60 percent of all stocks.
BIO has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on BIO!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 60 would rank higher than 60 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Bio-Rad Laboratories, Inc. Class A Common Stock Stock Today?
Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is trading at $713.69 as of 1:41 PM on Tuesday, Oct 12, a loss of -$4.21, or -0.59% from the previous closing price of $717.90. The stock has traded between $703.67 and $725.47 so far today. Volume today is low. So far 49,447 shares have traded compared to average volume of 137,066 shares.
Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
